Research ethics safeguard reviews should focus on results, not procedures, bioethics advisory panel told.
RESEARCH ETHICS SAFEGUARD REVIEWS SHOULD FOCUS ON RESULTS, NOT PROCEDURES, National Bioethics Advisory Commission Chair Harold Shapiro suggested at a Nov. 21 session of the "International Summit of Bioethics Advisory Boards" in San Francisco. "One of the things that plagues us is that accountability and bureaucracy go hand-in-glove," Shapiro said. "The more sure we want to be, the more checkers we need and the [more] checkers on the checkers....There really is no end to that, in principle."
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth